Provided by Tiger Trade Technology Pte. Ltd.

Bio-Techne

64.80
-0.6800-1.04%
Post-market: 64.800.00000.00%17:20 EST
Volume:1.71M
Turnover:110.92M
Market Cap:10.10B
PE:124.79
High:65.94
Open:65.48
Low:64.42
Close:65.48
52wk High:72.16
52wk Low:46.01
Shares:155.81M
Float Shares:154.93M
Volume Ratio:0.57
T/O Rate:1.10%
Dividend:0.32
Dividend Rate:0.49%
EPS(TTM):0.5193
EPS(LYR):0.4600
ROE:3.97%
ROA:6.52%
PB:5.02
PE(LYR):140.87

Loading ...

Bio-Techne Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Yesterday

Table: U-TECH Media Jan Rev NT$98.4M Vs NT$94.7M

Dow Jones
·
Feb 09

Bio-Techne Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Feb 07

Bio-Techne Corporation : Wells Fargo Raises Target Price to $76 From $70

THOMSON REUTERS
·
Feb 06

U.S. RESEARCH ROUNDUP-Amazon, Estée Lauder, Ralph Lauren

Reuters
·
Feb 06

Table: G-TECH Optoelectronics Jan Rev NT$273.5M Vs NT$179.0M

Dow Jones
·
Feb 06

Bio-Techne Corp. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Feb 06

Bio-Techne Is Maintained at In-Line by Evercore ISI Group

Dow Jones
·
Feb 05

Stifel Nicolaus Adjusts Bio-Techne PT to $65 From $60, Maintains Hold Rating

MT Newswires Live
·
Feb 05

Wells Fargo Adjusts Bio-Techne PT to $76 From $70, Maintains Overweight Rating

MT Newswires Live
·
Feb 05

Evercore ISI Adjusts Price Target on Bio-Techne to $68 From $62, Maintains In Line Rating

MT Newswires Live
·
Feb 05

Analysts Offer Insights on Healthcare Companies: Bio-Techne (TECH) and Aytu BioScience (AYTU)

TIPRANKS
·
Feb 05

U.S. RESEARCH ROUNDUP-Alphabet, Corteva, Varonis Systems

Reuters
·
Feb 05

Bio-Techne Earnings Call Balances Headwinds With Margin Gains

TIPRANKS
·
Feb 05

Analysts Offer Insights on Healthcare Companies: Neuren Pharmaceuticals Limited (OtherNURPF) and Bio-Techne (TECH)

TIPRANKS
·
Feb 05

Bio-Techne Corp. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
·
Feb 05

Bio-Techne: Near-Term Resilience and Margin Expansion Support Accelerating Growth and Buy Rating Into 2027

TIPRANKS
·
Feb 05

Bio-Techne price target raised to $80 from $70 at Citi

TIPRANKS
·
Feb 05

Stock Track | Bio-Techne Soars 5.14% in Pre-Market on Strong Q2 Earnings Beat and China/APAC Growth

Stock Track
·
Feb 04

Bio-Techne Shares up 2.54% After Q2 Results Beat Estimates

THOMSON REUTERS
·
Feb 04